What Role Can Employers Play in Cancer Prevention and Treatment?
New Rochelle, NY, August 13, 2013 - Employers can have a significant role in improving efforts to prevent and treat diseases such as cancer by introducing and supporting health promotion programs in the workplace. Together, companies can influence health care policies and reimbursement and industry practices to support the fight against cancer. Johnson & Johnson's active role in implementing the CEO Cancer Gold Standard program is described in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Population Health Management website.
Rachel Henke, PhD and coauthors representing Truven Health Analytics (Cambridge, MA and Washington, DC), Emory University (Atlanta, GA), and Johnson & Johnson (Southwest Ranches, FL, Mansfield, MA, and New Brunswick, NJ), focus on how J&J has incorporated the industry-leading standards developed by the CEO Roundtable on Cancer into its existing Live for Life worksite health promotion program.
In the article “Employers' Role in Cancer Prevention and Treatment—Developing Success Metrics for Use by the CEO Roundtable on Cancer,” the authors describe the “5 Pillars” of the CEO Cancer Gold Standard program, the framework J&J created to monitor the use and effectiveness of the cancer prevention and treatment enhancement efforts it introduced, and examples of the data collected by the company.
"This nationally prominent group of researchers has once again demonstrated that employers can bend the cost curve and improve outcomes, too,” says Editor-in-Chief David B. Nash, MD, MBA, Dean and Dr. Raymond C. and Doris N. Grandon Professor, Jefferson School of Population Health, Philadelphia, PA.
About the Journal
Population Health Management is an authoritative peer-reviewed journal published bimonthly in print and online that reflects the expanding scope of health care management and quality. The Journal delivers a comprehensive, integrated approach to the field of population health and provides information designed to improve the systems and policies that affect health care quality, access, and outcomes. Comprised of peer-reviewed original research papers, clinical research, and case studies, the content encompasses a broad range of chronic diseases (such as cardiovascular disease, cancer, chronic pain, diabetes, depression, and obesity) in addition to focusing on various aspects of prevention and wellness. Tables of content and a sample issue may be viewed on the Population Health Management website. Population Health Management is the Official Journal of the Care Continuum Alliance.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Journal of Women’s Health, Diabetes Technology & Therapeutics, and Metabolic Syndrome and Related Disorders. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
Posted: August 2013